EXHIBIT 4.1

==============================================================================



                              PURCHASE AGREEMENT


                                     Among


                        COMPANHIA BRASILEIRA DE BEBIDAS

                   COMPANHIA DE BEBIDAS DAS AMERICAS - AMBEV

                                      and

                         CITIGROUP GLOBAL MARKETS INC.
                     as Representative on behalf of itself
               and the other Initial Purchasers specified herein

                                  Relating to

                        Companhia Brasileira de Bebidas

                               U.S.$500,000,000

                             8.75% Notes Due 2013

                              September 11, 2003










==============================================================================



<PAGE>



                               TABLE OF CONTENTS

                                                                          Page

SECTION 1. Representations and Warranties....................................2

SECTION 2. Purchase and Sale................................................13

SECTION 3. Delivery and Payment.............................................13

SECTION 4. Offering by Initial Purchasers...................................14

SECTION 5. Covenants........................................................14

SECTION 6. Conditions to the Obligations of the Initial Purchasers..........18

SECTION 7. Reimbursement of Expenses........................................23

SECTION 8. Indemnification and Contribution.................................24

SECTION 9. Termination......................................................26

SECTION 10. Representations and Indemnities to Survive......................27

SECTION 11. Notices.........................................................27

SECTION 12. Successors......................................................27

SECTION 13. Jurisdiction....................................................27

SECTION 14. Governing Law...................................................28

SECTION 15. Currency........................................................28

SECTION 16. Waiver of Immunity..............................................28

SECTION 17. Counterparts....................................................28

SECTION 18. Entire Agreement................................................28

SECTION 19. Headings........................................................28



SCHEDULE I      List of Initial Purchasers

EXHIBIT A       Selling Restrictions




<PAGE>



                        COMPANHIA BRASILEIRA DE BEBIDAS
                   COMPANHIA DE BEBIDAS DAS AMERICAS - AMBEV

                               U.S.$500,000,000
                             8.75% Notes Due 2013

                              Purchase Agreement
                              ------------------

                                                            September 11, 2003

CITIGROUP GLOBAL MARKETS INC.
  as Representative on behalf of
  the Initial Purchasers set forth
  on Schedule I hereto
388 Greenwich Street
New York, New York 10013


Ladies and Gentlemen:

          Companhia Brasileira de Bebidas ("CBB"), a sociedade anonima
organized under the laws of the Federative Republic of Brazil ("Brazil") and a
majority-owned subsidiary of Companhia de Bebidas das Americas - AMBEV
("AMBEV" and, collectively with CBB, the "Companies") a sociedade anonima
organized and existing under the laws of Brazil, proposes to issue and sell to
Citigroup Global Markets Inc. (the "Representative") and the other initial
purchasers set forth on Schedule I hereto (collectively, the "Initial
Purchasers") U.S.$500,000,000 principal amount of its 8.75% Notes Due 2013
(the "Notes"). The Notes are to be issued under an Indenture (the "Indenture")
to be dated the Closing Date (as defined herein) among CBB, The Bank of New
York, as trustee and as paying agent in New York (the "Trustee") and The Bank
of New York (Luxembourg) S.A., as paying agent in Luxembourg and as Luxembourg
transfer agent. All of CBB's obligations under the Notes will have the benefit
of certain credit support provided by (i) AMBEV, in the form of a Guaranty
(the "Guaranty") to be dated the Closing Date between it and the Trustee,
pursuant to which AMBEV will agree, subject to certain conditions, to
guarantee payment of principal, interest and other amounts due on or with
respect to the Notes if not paid by CBB within specified time periods, (ii)
Steadfast Insurance Company (the "Insurer"), a Delaware insurance company and
a wholly-owned subsidiary of Zurich American Insurance Company, a member of
the Zurich Financial Services Group, an insurance holding company organized
under the laws of Switzerland, in the form of an Insurance Policy for
Expropriation and Currency Inconvertibility to be issued on the Closing Date
in favor of the Trustee on behalf of the holders of the Notes (the "Insurance
Policy"), pursuant to which the Insurer will provide, subject to certain
conditions, limited protection against the inability of AMBEV, CBB and the
Trustee to convert Brazilian reais into U.S. dollars or transfer to the
Trustee these U.S. dollars in satisfaction of amounts to be paid by CBB and
AMBEV under the Notes, the Indenture and the Guaranty, as the case may be,
(iii) the irrevocable standby letter of credit to be issued on the Closing
Date by Citibank N.A., and any replacement thereof (the "Letter of Credit")
for the benefit of the Trustee and (iv) a reserve account (the "Reserve
Account") to be established on the Closing Date by CBB with the Trustee

<PAGE>



pursuant to the Indenture and amounts deposited therein from time to time
pursuant to the Indenture. Terms not otherwise defined herein are used as
defined in the Indenture.

          The Initial Purchasers and their direct and indirect transferees of
the Notes will also be entitled to the benefit of a Registration Rights
Agreement (the "Registration Rights Agreement") to be entered into among CBB,
AMBEV and the Representative, on behalf of the Initial Purchasers, pursuant to
which CBB and AMBEV will agree, among other things, to file a registration
statement with the Securities and Exchange Commission (the "Commission")
registering securities (the "Exchange Notes") under the United States
Securities Act of 1933, as amended (the "Securities Act"), with identical
terms as the Notes (except that the Exchange Notes will not contain provisions
requiring CBB and AMBEV to register the Exchange Notes or provisions regarding
restrictions on transfer) and to consummate an exchange offer exchanging the
Notes for the Exchange Notes, in each case subject to the terms and conditions
therein specified.

          The Notes will be offered and sold by CBB to the Initial Purchasers
without registration under the Securities Act, in reliance upon exemptions
from the registration requirements of the Securities Act. CBB understands that
the Initial Purchasers propose to make an offering of the Notes, as soon as
the Representative deems advisable after this Purchase Agreement (this
"Purchase Agreement") has been executed and delivered, to persons in the
United States whom the Initial Purchasers reasonably believe to be qualified
institutional buyers ("QIBs") as defined in Rule 144A under the Securities
Act, as such rule may be amended from time to time ("Rule 144A"), in
transactions meeting the requirements of Rule 144A, and to non-U.S. persons in
transactions meeting the requirements of Regulation S under the Securities
Act, as such regulation may be amended from time to time ("Regulation S").

          In connection with the offer and sale of the Notes, the Companies
have prepared a preliminary offering memorandum, dated September 4, 2003,
including any and all exhibits thereto (the "Preliminary Memorandum"), and a
final offering memorandum dated the date hereof, including any and all
exhibits thereto (the "Final Memorandum" and, together with the Preliminary
Memorandum and any amendments or supplements to either the Preliminary
Memorandum or the Final Memorandum prior to the time of purchase, the
"Offering Memoranda"). Each of the Preliminary Memorandum and the Final
Memorandum sets forth certain information concerning the Companies and the
Notes. The Companies hereby confirm that they have authorized the use of the
Preliminary Memorandum and the Final Memorandum, and any amendment or
supplement thereto, in connection with the offer and sale of the Notes by the
Initial Purchasers. Unless stated to the contrary, all references to the Final
Memorandum are to the Final Memorandum at the date hereof and are not meant to
include any amendment or supplement, subsequent thereto.

          SECTION 1. Representations and Warranties. Each of the Companies
jointly and severally represents and warrants, as of the date hereof and on
the Closing Date, to the Initial Purchasers as set forth below:

          (a) On the date hereof, the Final Memorandum did not, and on the
     Closing Date (as defined below) will not, contain any untrue statement of
     a material fact or omit to state any material fact necessary to make the
     statements therein, in the light of the



                                      2
<PAGE>



     circumstances under which they were made, not misleading. Notwithstanding
     the foregoing, the Companies do not make any representation or warranty
     as to the information contained in or omitted from the Preliminary
     Memorandum or the Final Memorandum, or any amendment or supplement
     thereto, in reliance upon and in conformity with information furnished as
     set forth in Section 8(b) hereof to the Companies by the Representative,
     on behalf of the Initial Purchasers, or by the Insurer, specifically for
     inclusion therein.

          (b) The offer, issuance and sale of the Notes in the manner
     contemplated by the Final Memorandum will not require registration of the
     same under the Securities Act or qualification of the Notes under the
     United States Trust Indenture Act of 1939, as amended (the "TIA").
     Neither of the Companies, nor any of their "Affiliates" (as defined in
     Rule 501(b) of the Regulation D under the Securities Act ("Regulation
     D")), nor any person acting on their behalf has, directly or indirectly,
     made offers or sales of any security, or solicited offers to buy any
     security, under circumstances that would require the registration of the
     Notes under the Securities Act.

          (c) Neither of the Companies, nor any of their Affiliates, nor any
     person acting on their behalf, has engaged in any form of general
     solicitation or general advertising (within the meaning of Rule 502(c) of
     Regulation D) in connection with any offer or sale of the Notes in the
     United States.

          (d) The Notes satisfy the eligibility requirements of Rule
     144A(d)(3) under the Securities Act and, assuming the accuracy of the
     representations and warranties of the Representative, on behalf of the
     Initial Purchasers, set forth in Section 4 hereof, the offering of the
     Notes in the manner set forth in the Final Memorandum has been made in
     compliance with the applicable requirements, including all applicable
     informational requirements, of Rule 144A and Regulation S, as the case
     may be.

          (e) CBB is a "foreign private issuer" (as defined in Regulation S),
     and neither of the Companies, nor any of their Affiliates, nor any person
     acting on their behalf (other than the Initial Purchasers as to which the
     Companies make no representation or warranty) has engaged in any directed
     selling efforts (as defined in Rule 902 of Regulation S) with respect to
     the Notes, or otherwise taken any action that is not consistent with any
     of the offering restrictions of Rule 144A or Regulation S, as the case
     may be, with respect to the Notes.

          (f) Each of the Companies reasonably believes that there is no
     substantial U.S. market interest (as defined in Regulation S) in the
     Notes.

          (g) Neither of the Companies is, and after giving effect to the
     offering and sale of the Notes and the application of the proceeds
     thereof as described in the Final Memorandum will not be, an "investment
     company" or a company "controlled by" an "investment company" as such
     terms are defined in the United States Investment Company Act of 1940, as
     amended (the "Investment Company Act"), and the rules and regulations of
     the Commission promulgated thereunder.



                                      3
<PAGE>



          (h) No person has the right to require that the Companies register
     any securities (other than the Notes or the Exchange Notes, if any) for
     offering and sale under the Securities Act by reason of the filing of the
     registration statement contemplated by the Registration Rights Agreement.

          (i) Neither of the Companies, nor any of their Affiliates, nor any
     person acting on their behalf, has paid or agreed to pay to any person
     any compensation for soliciting another to purchase (i) the Notes or (ii)
     any other securities of CBB within the last 90 days, except in the case
     of either (i) or (ii) as contemplated by this Purchase Agreement.

          (j) Neither of the Companies, nor, to the best knowledge of the
     Companies, any of their Affiliates, nor any person acting on their behalf
     (other than the Initial Purchasers, as to which the Companies make no
     representation or warranties), has, directly or indirectly, taken any
     action designed to cause or which has constituted or which might
     reasonably be expected to cause or result in the stabilization or
     manipulation of the price of any security of either of the Companies to
     facilitate the initial sale or resale of the Notes under the United
     States Securities Exchange Act of 1934, as amended (the "Exchange Act"),
     or otherwise, except as permitted by this Purchase Agreement.

          (k) AMBEV is in compliance with all of its periodic reporting and
     other requirements under the Exchange Act; all reports heretofore filed
     by AMBEV under the Exchange Act complied as to form with the requirements
     applicable thereto and did not contain any material misstatement or omit
     to state any material facts necessary to make the statements contained
     therein not misleading.

          (l) None of the information heretofore provided to the Insurer in
     connection with the application for, and issuance of, the Insurance
     Policy, at the date thereof, contained or will contain any material
     misrepresentation.

          (m) CBB has been duly incorporated and is validly existing as a
     sociedade anonima in good standing under the laws of Brazil or, in the
     case of each of its subsidiaries, has been duly incorporated and are
     validly existing as a corporation in good standing (if applicable) under
     the laws of the jurisdiction in which they were chartered or organized.
     CBB has the full corporate power and authority to own or lease, as the
     case may be, and to operate its properties and conduct its business as
     described in the Final Memorandum and to enter into and perform its
     obligations, as applicable, under this Purchase Agreement, the Indenture,
     the Notes, the Exchange Notes, the Registration Rights Agreement, the
     Guaranty, the Insurance Policy, the Insurance Side Agreement, the DTC
     Letter of Representations completed by CBB and the Trustee in connection
     with the Notes and the Letter of Credit (collectively, the "Transaction
     Documents"), to which it is a party, and is duly qualified to do business
     as a foreign corporation under the laws of each jurisdiction which
     requires such qualification except where the failure to be so qualified
     will not have a Material Adverse Effect. For the purposes of this
     Purchase Agreement, the term "Material Adverse Effect" shall mean (i) any
     material adverse effect on the condition (financial or otherwise),
     results of operation, or prospects of either of the Companies, together
     with their respective consolidated subsidiaries, (ii) any material



                                      4
<PAGE>



     adverse effect on the ability of CBB, AMBEV or any other person to
     perform their respective material obligations under any of the
     Transaction Documents or (iii) any material adverse effect on the rights
     of the Trustee, acting on behalf of the holders of the Notes, or such
     holders, under any of the Transaction Documents.

          (n) AMBEV has been duly organized and is validly existing as a
     sociedade anonima in good standing under the laws of Brazil or, in the
     case of each of its subsidiaries has been duly incorporated and is
     validly existing as a corporation in good standing (if applicable) under
     the laws of the jurisdiction in which it is chartered or organized. Each
     of AMBEV and its subsidiaries is licensed (if and to the extent
     necessary) and has the full corporate power and authority to own or
     lease, as the case may be, and to operate its properties and to conduct
     its business as described in the Final Memorandum and to enter into and
     perform its obligations under this Purchase Agreement and the other
     Transaction Documents to which it is a party, and is duly qualified or
     licensed as a foreign corporation in good standing in each jurisdiction
     which requires such qualification, except, in the case of its
     subsidiaries other than CBB, where the failure to be so qualified will
     not have a Material Adverse Effect. AMBEV owns 99.99% of the outstanding
     voting equity interests of CBB. All ownership information contained on
     page A-1 of the Offering Memoranda is true and correct in all material
     respects.

          (o) All of the outstanding shares of capital stock, if any, of each
     of AMBEV's subsidiaries have been duly and validly authorized and issued
     and are fully paid and nonassessable except, in the case of the
     subsidiaries (other than CBB), as would not have a Material Adverse
     Effect, and all outstanding shares of capital stock of the subsidiaries
     are owned by the Companies, as the case may be, either directly or
     through majority-owned subsidiaries are free and clear of any perfected
     security interest or any other security interests, claims, liens or
     encumbrances.

          (p) AMBEV's capitalization is as set forth in the Final Memorandum.

          (q) This Purchase Agreement has been duly authorized, executed and
     delivered by each of the Companies; each of the Indenture, the Guaranty,
     the Insurance Side Agreement and the Registration Rights Agreement and
     each other document executed and delivered in connection therewith to
     which either of the Companies is party has been duly authorized and,
     assuming due authorization, execution and delivery thereof by each other
     party to those Transaction Documents (other than the Companies), when
     executed and delivered by the Companies, will constitute a legal, valid
     and binding agreement of the Companies, as the case may be, enforceable
     against each of the Companies in accordance with its terms (subject, as
     to the enforcement of remedies, to applicable bankruptcy, reorganization,
     insolvency, moratorium or other similar laws affecting creditors' rights
     generally from time to time in effect and to general principles of
     equity).

          (r) The descriptions of the Transaction Documents in the Final
     Memorandum fairly summarize the rights and obligations of the parties
     thereto. The statements in the



                                      5
<PAGE>



     Final Memorandum under the caption "Material Tax Considerations" fairly
     summarize the matters described therein.

          (s) The Notes have been duly authorized, and, when issued under the
     Indenture, authenticated by the Trustee and delivered to and paid for by
     the Initial Purchasers pursuant to this Purchase Agreement, will have
     been duly executed, issued and delivered and will constitute legal, valid
     and binding obligations of CBB, enforceable in accordance with their
     terms, subject, as to the enforcement of remedies, to applicable
     bankruptcy, reorganization, insolvency, moratorium, or other similar laws
     affecting creditors' rights generally from time to time in effect and to
     general principles of equity and will be entitled to the benefits
     provided by the Indenture as described in the Final Memorandum; the
     Exchange Notes have been duly authorized and, when issued, authenticated
     by the Trustee and delivered in exchange for the Notes, will have been
     duly executed, issued and delivered and will constitute legal, valid and
     binding obligations of CBB, enforceable in accordance with their terms,
     subject, as to enforcement of remedies, as provided above.

          (t) Each of the Notes and the Exchange Notes, if any, will
     constitute the general, direct, unsecured and unconditional obligations
     of CBB and will rank pari passu in priority of payment and in right of
     security with all other unsecured obligations of CBB that are not, by
     their terms, expressly subordinated in right of payment to the Notes or
     the Exchange Notes, if any, except for statutory liens and preferences.
     The obligations of AMBEV under the Guaranty will constitute the general,
     direct and unconditional obligations of AMBEV and will rank pari passu in
     priority of payment and in right of security with all other unsecured
     obligations of AMBEV that are not, by their terms, expressly subordinated
     in right of payment to the rights of the Trustee under the Guaranty,
     except for statutory liens and preferences.

          (u) No consent, approval, authorization, filing with or order of any
     court or governmental agency or other regulatory authority or body having
     jurisdiction over either of the Companies or any of their respective
     properties or assets in Brazil or elsewhere ("Government Authorities") is
     required for (i) the valid authorization, issuance, sale and delivery of
     the Notes, (ii) the execution, delivery or performance by the Companies
     of any of their respective obligations under any of the Transaction
     Documents in the manner contemplated in the Final Memorandum, including,
     without limitation, making any of the applicable payments required to be
     made after the date hereof under or in respect of any of the Transaction
     Documents or (iii) the issuance, exchange and delivery of the Exchange
     Notes, except as has been obtained or completed or such as will be
     obtained in accordance with the Registration Rights Agreement under the
     Securities Act or the TIA, other than (A) any such authorization,
     approval, action, notice or filing which has been obtained or made, as
     the case may be, prior to the date hereof or will be obtained or made
     prior to the Closing Date and will be in full force and effect on the
     Closing Date, including the electronic registration (the "Electronic
     Registration") with the Brazilian Central Bank (the "Central Bank") that
     will be obtained prior to the Closing Date and will be in full force and
     effect on the Closing Date and (B) any further authorization from the
     Central Bank in order to enable CBB and AMBEV to make remittances from
     Brazil in U.S. dollars to make payments under the Notes, the Indenture
     and the Guaranty or any




                                      6
<PAGE>

     other Transaction Documents not specifically covered by the Electronic
     Registration (including payments made after 120 days from their
     originally scheduled due date and payments in different conditions as a
     result of the issuance of the Exchange Notes) or to make payments
     specifically covered by the Electronic Registration earlier than their
     respective due dates, whether upon acceleration or otherwise.

          (v) Neither of the Companies is currently in violation of its
     charter, by-laws or comparable organizational documents; neither the
     issuance and sale of the Notes, the execution and delivery of any of the
     Transaction Documents nor the consummation of any of the transactions
     described or contemplated therein, nor the fulfillment of the terms
     thereof will conflict with, or give rise to any right to accelerate the
     maturity or require the prepayment, repurchase or redemption of any
     indebtedness under, or result in a breach or violation or imposition of
     any lien, charge or encumbrance upon any property or assets of the
     Companies or any of their subsidiaries pursuant to, (i) the charter,
     by-laws or comparable organizational documents of either of the Companies
     or any of their subsidiaries, (ii) the terms of any indenture, contract,
     lease, mortgage, deed of trust, note agreement, loan agreement or other
     agreement, obligation, condition, covenant or instrument to which the
     Companies or any of their subsidiaries is a party or bound or to which
     any of their property or assets is subject or (iii) any statute, law,
     rule, regulation, judgment, order or decree applicable to the Companies
     or any of their subsidiaries, except in the case of clauses (ii) or (iii)
     such as could not reasonably be expected to have a Material Adverse
     Effect.

          (w) The consolidated historical financial statements of AMBEV and
     its consolidated subsidiaries included in the Offering Memoranda
     (including any reconciliation to U.S. GAAP), together with the related
     notes, have been prepared in accordance with accounting principles
     generally accepted in Brazil applied on a consistent basis throughout the
     periods involved (except as otherwise noted therein) and present fairly
     in all material respects the financial condition, results of operations
     and cash flows of the Companies as of the dates and for the periods
     indicated; the summary and selected financial data set forth under the
     captions "Summary Financial Information" and "Selected Financial Data" in
     the Offering Memoranda fairly present, on the basis stated in the
     Offering Memoranda, the information included therein. Subsequent to the
     later of June 30, 2003 and the respective dates as of which information
     is given in the Offering Memoranda and except as disclosed in the
     Offering Memoranda, there has been no material adverse change in the
     operations, business, property or assets of or in the financial condition
     of either of the Companies and their consolidated subsidiaries, taken as
     a whole.

          (x) Subsequent to the respective dates as of which information is
     given in the Offering Memoranda and except as set forth or contemplated
     in the Offering Memoranda, neither of the Companies has entered into any
     transaction or agreement (whether or not in the ordinary course of
     business) material to either of the Companies individually or the
     Companies taken as a whole with their consolidated subsidiaries.

          (y) Except as set forth or contemplated in the Offering Memoranda,
     no action, suit or proceeding by or before any Government Authority
     involving the Companies or



                                      7
<PAGE>



     any of their subsidiaries or their property or assets is pending or, to
     the best knowledge of the Companies, threatened, involving or in any way
     relating to (i) this Purchase Agreement, any of the other Transaction
     Documents or the transactions contemplated herein or therein or (ii) any
     other matter that individually or in the aggregate could reasonably be
     expected to have a Material Adverse Effect, except as set forth in or
     contemplated in the Final Memorandum. Neither the Companies nor any of
     their subsidiaries is in default with respect to any applicable statute,
     rule, writ, injunction, decree, order or regulation of any Government
     Authority having jurisdiction over such person which is reasonably likely
     to have a Material Adverse Effect on the Companies or the ability of the
     Companies to perform their obligations under this Purchase Agreement and
     each other Transaction Document to which they are a party.

          (z) Except as set forth or contemplated in the Offering Memoranda,
     each of the Companies and each of their respective subsidiaries has good
     and marketable title to all of their properties and assets and owns or
     leases all such properties and assets as are both described in the
     Offering Memoranda and necessary to the conduct of its operations as
     presently conducted free and clear of any liens, charges, security
     interests or other encumbrances except such as (i) do not materially
     interfere with the intended use thereof and (ii) could not reasonably be
     expected to have a Material Adverse Effect. All leases and subleases
     material to the business of each of the Companies under which either of
     the Companies holds properties, as described in the Offering Memoranda,
     are in full force and effect; and neither of the Companies has had any
     notice that any material claim of any sort has been asserted by anyone
     adverse to the Companies' rights under any leases or subleases mentioned
     above, or affecting or questioning the rights thereof to the continued
     possession of the leased or subleased premises under any such lease or
     sublease, except as would not result in a Material Adverse Effect.

          (aa) PricewaterhouseCoopers Auditores Independentes, who have
     certified the financial statements of AMBEV and its consolidated
     subsidiaries and delivered their report with respect to the audited
     consolidated financial statements included in the Final Memorandum, are
     independent public accountants within the meaning of Rule 101 of the Code
     of Professional Conduct of the American Institute of Certified Public
     Accountants and the applicable requirements of the Regulation S-X of the
     Securities Act and the Exchange Act and are certified public accountants
     with respect to the Companies under the standards established by the
     local authorities in Brazil.

          (bb) Except as otherwise disclosed in the Offering Memoranda, no
     labor problem or dispute with the employees of the Companies or any of
     their subsidiaries exists or, to the Companies' knowledge, is threatened
     or imminent that could reasonably be expected to have a Material Adverse
     Effect.

          (cc) Each of the Companies and their respective subsidiaries has
     filed or caused to be filed all tax returns which to the knowledge of the
     Companies are required to be filed, and has paid all taxes shown to be
     due and payable on said returns or on any assessments made against such
     person or any of its respective properties and all other taxes,
     assessments, fees or other charges imposed on such person or any of its
     respective properties by, any Governmental Authority (other than those
     the amount or validity of



                                      8
<PAGE>



     which is currently being contested in good faith by appropriate
     proceedings and with respect to which reserves in conformity with
     generally accepted accounting principles have been provided on the books
     of such person or such as would not, in the aggregate, have a Material
     Adverse Effect); and no tax liens or liens with respect to any
     assessments, fees or other charges have been filed and, to the knowledge
     of such person, no claims are being asserted with respect to any such
     taxes, assessments, fees or other charges which might have a Material
     Adverse Effect.

          (dd) The Companies and each of their respective subsidiaries are
     insured by insurers of recognized financial responsibility against such
     losses and risks and in such amounts as are prudent and customary in the
     businesses except where the failure to maintain such insurance would not
     have a Material Adverse Effect and in the geographical regions in which
     they are engaged; and neither of the Companies nor any subsidiary thereof
     has any reason to believe that it will not be able to renew its existing
     insurance coverage as and when such coverage expires or to obtain similar
     coverage from similar insurers as may be necessary to continue its
     business at a cost that would not have a Material Adverse Effect.

          (ee) No subsidiary of the Companies is currently prohibited,
     directly or indirectly, from paying any dividends to either of the
     Companies, from making any other distribution on such subsidiary's
     capital stock, from repaying to the Companies any loans or advances to
     such subsidiary from the Companies or from transferring any of such
     subsidiary's property or assets to the Companies or any other subsidiary
     of the Companies.

          (ff) Except as set forth or contemplated in the Offering Memoranda,
     the Companies and their subsidiaries possess all licenses, certificates,
     permits and other authorizations issued by the appropriate federal, state
     or foreign regulatory authorities necessary to conduct their respective
     businesses except where the failure to have any such authorization would
     not have a Material Adverse Effect, and neither of the Companies nor any
     of their subsidiaries has received any notice of proceedings relating to
     the revocation or modification of any such certificate, authorization or
     permit which, singly or in the aggregate, if the subject of an
     unfavorable decision, ruling or finding, could have a Material Adverse
     Effect.

          (gg) To ensure the legality, validity, enforceability or
     admissibility into evidence of any of the Transaction Documents, it is
     not necessary that any such other document be filed or recorded with any
     court or other authority in Brazil (other than such authorizations or
     filings that have already been obtained or made, as applicable), or that
     any stamp or similar tax be paid in either Brazil on or in respect of any
     such document, except (i) as provided in the Offering Memoranda and
     herein or (ii) that (1) the signatures of the parties to the Transaction
     Documents or the other documents who have signed the respective document
     outside Brazil need to be notarized by a notary public licensed as such
     under the law of the place of signing and the signature of such notary
     public needs to be authenticated by a Brazilian consulate, (2) the
     Transaction Documents or the other documents need to be translated into
     Portuguese by a certified translator and (3) the Transaction Documents or
     the other documents, together with their respective certified




                                      9
<PAGE>



     translations into the Portuguese language, need to be registered with the
     appropriate Registry of Deeds and Documents (Registro de Titulos e
     Documentos), which registration can be made at any time prior to judicial
     enforcement thereof in Brazil. It is not necessary under the laws of
     Brazil that any of the holders of the Notes or the Exchange Notes, if
     any, be licensed, qualified or entitled to carry on business in Brazil by
     reason of the execution, delivery, performance or enforcement of any of
     the Transaction Documents, but the holders of the Notes resident outside
     of Brazil that own no real property in Brazil will be required to post a
     bond sufficient to guarantee court costs and legal fees to bring a
     judicial enforcement action in Brazil.

          (hh) The Companies and each of their respective subsidiaries each
     maintain a system of internal accounting controls sufficient to provide
     reasonable assurance that (i) transactions are executed in accordance
     with management's general or specific authorizations, (ii) transactions
     are recorded as necessary to permit preparation of financial statements
     in accordance with accounting principles generally accepted in Brazil and
     to maintain asset accountability, (iii) access to assets is permitted
     only in accordance with management's general or specific authorization
     and (iv) the recorded accountability for assets is compared with the
     existing assets at reasonable intervals and appropriate action is taken
     with respect to any differences, except where the failure to maintain any
     such system would not have a Material Adverse Effect.

          (ii) Except as set forth or contemplated in the Offering Memoranda,
     the Companies and their respective subsidiaries (i) are in compliance
     with any and all applicable foreign, federal, state and local laws and
     regulations relating to the protection of human health and safety, the
     environment or hazardous or toxic substances or wastes, pollutants or
     contaminants ("Environmental Laws"), (ii) have received and are in
     compliance with all permits, licenses or other approvals required of them
     under the applicable Environmental Laws to conduct their respective
     businesses and (iii) have not received notice of any actual or potential
     liability for the investigation or remediation of any disposal or release
     of hazardous or toxic substances or wastes, pollutants or contaminants,
     except where such non-compliance with Environmental Laws, failure to
     receive or comply with required permits, licenses or other approvals, or
     liability would not, individually or in the aggregate, have a Material
     Adverse Effect. Except as set forth in the Final Memorandum, neither of
     the Companies nor any of their subsidiaries has been named as a
     "potentially responsible party" under the United States Comprehensive
     Environmental Response, Compensation, and Liability Act of 1980, as
     amended, nor has the Company or any such subsidiary been identified as
     the party responsible or potentially responsible for any breach or
     violation of any other similar Environmental Law, except where such
     naming or identification would not, individually or in the aggregate,
     have a Material Adverse Effect.

          (jj) Except as set forth or contemplated in the Offering Memoranda,
     in the ordinary course of its business, the Companies periodically review
     the effect of Environmental Laws on the business, operations and
     properties of the Companies and their subsidiaries, in the course of
     which it identifies and evaluates associated costs and liabilities
     (including, without limitation, any capital or operating expenditures
     required for clean-up, closure of properties or compliance with
     Environmental Laws, or any



                                      10
<PAGE>



     permit, license or approval, any related constraints on operating
     activities and any potential liabilities to third parties). On the basis
     of such review, the Companies have reasonably concluded that such
     associated costs and liabilities could not, singly or in the aggregate,
     have a Material Adverse Effect.

          (kk) The Companies and their subsidiaries own, possess, license or
     have other rights to use, on reasonable terms, all patents, patent
     applications, trade and service marks, trade and service mark
     registrations, trade names, copyrights, licenses, inventions, trade
     secrets, technology, know-how and other intellectual property necessary
     for the conduct of the Companies' businesses as now conducted or as
     described in the Final Memorandum to be conducted by them and neither the
     Companies nor any of their subsidiaries has received any notice of
     infringement or of conflict with asserted rights of others with respect
     to any of the foregoing which, singly or in the aggregate, if the subject
     of an unfavorable decision, ruling or funding, could reasonably be
     expected to result in any Material Adverse Effect.

          (ll) To the best of the Companies' knowledge, the indemnification
     and contribution provisions set forth in Section 8 hereof do not
     contravene Brazilian law or public policy, subject to recognition and
     enforcement provisions described in clause (nn) below.

          (mm) The Companies are subject to civil and commercial law in
     respect of their obligations hereunder and the Companies are not, nor are
     any of their properties, assets or revenues subject to any right of
     immunity under Brazilian or New York law, from any legal action, suit or
     proceeding, from the giving of any relief in any such legal action, suit
     or proceeding, from set-off or counterclaim, from the jurisdiction of any
     Brazilian, New York or U.S. federal court, from service of process,
     attachment upon or prior to judgment, or attachment in aid of execution
     of judgment, or from execution of a judgment, or other legal process or
     proceeding for the giving of any relief or for the enforcement of a
     judgment, in any such court with respect to its obligations, liabilities
     or any other matter under or arising out of or in connection herewith;
     and, to the extent that the Companies or any of their properties, assets
     or revenues may have or may hereafter become entitled to any such right
     of immunity in any such court in which proceedings arising out of, or
     relating to the transactions contemplated hereby, may at any time be
     commenced, the Companies have waived or will waive such right to the
     extent permitted by law and have consented to such relief and enforcement
     as provided herein.

          (nn) The submission of the Companies to the exclusive jurisdiction
     of the courts of the Supreme Court of the State of New York, County of
     New York, and the United States District Court for the Southern District
     of New York (each, a "New York court") in Section 13 hereof and under
     each of the Transaction Documents is legal, valid and binding under the
     laws of Brazil; the appointment of CT Corporation System, at its offices
     located at 111 Eighth Avenue, New York, New York 10011, as its authorized
     agent for the purpose described in Section 13 below and under each of the
     other Transaction Documents is legal, valid and binding under the laws of
     Brazil and choice of law provision set forth in Section 14 below and in
     each Transaction Document is legal, valid and binding under the laws of
     Brazil. Any final judgment of a New York court in





                                      11
<PAGE>

     respect of any amount payable by the Companies under any Transaction
     Document and which conforms with Brazilian law, rule, regulation or
     public policy will be enforceable in the courts of Brazil without
     reexamination of the merits provided that such judgment is ratified by
     the Brazilian Supreme Court (Supremo Tribunal Federal). Such ratification
     will occur without reexamination of the merits provided that such final
     judgment (i) fulfills all formalities required for enforceability under
     the laws of the country that granted the foreign judgment, (ii) was
     issued by a competent court in the jurisdiction where it was awarded
     after service of process was properly made in accordance with Brazilian
     law, (iii) is final and, therefore, not subject to appeal in the
     jurisdiction in which it was issued, (iv) is for the payment of a sum
     certain of money, (v) has been duly authenticated by a Brazilian
     consulate in the country wherein it was issued and is accompanied by a
     certified sworn translation of such judgment into Portuguese, and (vi) is
     not contrary to Brazilian national sovereignty, public policy and good
     morals (as provided in Article 17 of Decree Law No. 4657/42), and does
     not contain any provision that for any reason would not be upheld by the
     courts of Brazil.

          (oo) Any final judgment for a fixed or determined sum of money
     rendered by any court of the State of New York or of the United States
     located in the State of New York having jurisdiction under its own
     domestic laws in respect of any suit, action or proceeding against the
     Companies based upon any Transaction Document would be declared
     enforceable against the Companies by the courts of Brazil without
     re-examination, review of the merits of the cause of action in respect of
     which the original judgment was given or relitigation of the matters
     adjudicated upon or payment of any stamp, registration or similar tax or
     duty, subject to the provisions for enforcement of foreign judgments set
     forth in the Final Memorandum. Any judgment obtained against the
     Companies in the courts of Brazil in respect of any sum payable by it
     under any of the Transaction Documents would be expressed in Brazilian
     currency equivalent to the amount of United States dollars at the
     commercial rate prevailing on the date that the payment is actually made.

          (pp) No part of the proceeds of the sale of the Notes will be used
     for any purpose that violates the provisions of any of Regulation T, U or
     X of the Board of Governors of the Federal Reserve System or any other
     regulation of such Board of Governors.

          (qq) Both presently and immediately after giving effect to the
     transactions contemplated hereunder, each of the Companies (i) is and
     will be able to pay its debts as they become due and (ii) is not
     insolvent as defined under applicable Brazilian bankruptcy, insolvency or
     similar law.

          (rr) None of the holders of the Notes or the Exchange Notes, the
     Initial Purchasers or the Trustee will be deemed resident, domiciled,
     carrying on business or subject to taxation in Brazil solely by the
     execution, delivery, performance or enforcement of any of the Transaction
     Documents or by virtue of the ownership or transfer of a Note or Exchange
     Note or the receipt of payment thereon assuming that none of such persons
     is a resident of Brazil or has a permanent establishment or a fixed base
     in Brazil.



                                      12
<PAGE>



          (ss) There are no Brazilian taxes on or by virtue of the execution
     or delivery of this Purchase Agreement, the Indenture, the Notes, the
     Exchange Notes or any of the other Transaction Documents or any other
     document to be furnished hereunder or thereunder. Except as described in
     the Final Memorandum, payments to be made by the Companies or any other
     party to any of the Transaction Documents pursuant to the Transaction
     Documents will not be subject to Brazilian taxes of any kind. There are
     no stamp or other issuance or transfer taxes or duties or other similar
     fees or charges required to be paid in connection with the execution and
     delivery of any of the Transaction Documents or the consummation of any
     of the other transactions described therein or the issuance and sale by
     CBB of the Notes.

          (tt) Application has been made to list the Notes on the Luxembourg
     Stock Exchange and neither of the Companies has any reason to believe
     such listing will not be approved by the issuance of the Notes as
     contemplated hereunder.

          SECTION 2. Purchase and Sale. Subject to the terms and conditions
and in reliance upon the representations and warranties herein set forth, CBB
agrees to sell the Notes to the Initial Purchasers, and the Initial Purchasers
agree to purchase the Notes from CBB, at a purchase price of 99.674% of the
aggregate principal amount of the Notes (the "Purchase Price").

          SECTION 3. Delivery and Payment. (a) Delivery of and payment for the
Notes shall be made at the offices of Shearman & Sterling LLP in New York or
such other place as shall be agreed upon by the parties hereto at 10:00 A.M.,
New York City time, on September 18, 2003, or at such time on such later date
(not later than September 25, 2003) as the Representative shall designate,
which date and time may be postponed by agreement between the Representative
and CBB or as provided in Section 9 hereof (such date and time of delivery and
payment for the Notes being herein called the "Closing Date"). Delivery of the
Notes shall be made to the Representative against payment by the Initial
Purchasers of U.S.$495,870,000 (the "Net Proceeds") to or upon the order of
CBB by wire transfer payable in immediately available funds to the account
specified in writing by CBB not less than three Business Days prior to the
Closing Date. The Net Proceeds shall represent an amount equal to (i)
U.S.$498,370,000 as the Purchase Price less (ii) an amount payable to the
Initial Purchasers equal to 0.50% of the U.S.$500,000,000 aggregate principal
amount of the Notes to be issued on the Closing Date or U.S.$2,500,000 (the
"Selling Commission"). Delivery of the Notes shall be made through the
facilities of The Depository Trust Company ("DTC") unless the Representative
shall otherwise instruct.

          (b) CBB agrees to arrange to have the Notes available for
inspecting, checking and packaging by the Representative, on behalf of the
Initial Purchasers in New York, New York not later than 1:00 p.m. on the
Business Day prior to the Closing Date.

          (c) For the purposes of this Purchase Agreement, the term "Business
Day" means each Monday, Tuesday, Wednesday, Thursday and Friday that is not a
day on which banking institutions in the City of New York are authorized or
obligated by law, executive order or regulation to close.



                                      13
<PAGE>



          SECTION 4. Offering by Initial Purchasers. The Representative, on
behalf of the Initial Purchasers, represents and warrants to and agrees with
the Companies that:

          (a) No Initial Purchaser has offered or sold, nor will any of the
     Initial Purchasers offer or sell, any Notes except (i) inside the United
     States or to U.S. Persons to only those U.S. Persons that such Initial
     Purchaser reasonably believes to be QIBs and that, in connection with
     each such sale, each Initial Purchaser has taken or will take reasonable
     steps to ensure that the purchaser of such Notes is aware that such sale
     is being made in reliance on Rule 144A, or (ii) outside the United States
     in accordance with the restrictions set forth in Regulation S, as
     described in Exhibit A hereto.

          (b) No Initial Purchaser nor any person acting on its behalf has
     made or will make offers or sales of the Notes in the United States by
     means of any form of general solicitation or general advertising (within
     the meaning of Rule 502(c) of Regulation D) in the United States. With
     respect to the Notes sold in reliance on Regulation S, no Initial
     Purchaser has engaged nor will any such Initial Purchaser engage in any
     directed selling efforts in the United States (within the meaning of
     Regulation S).

          (c) The Initial Purchasers will not engage in any activity that
     reasonably can be expected to cause or result, under the Exchange Act or
     otherwise, in stabilization or manipulation of the price of any security
     of CBB or AMBEV to facilitate the sale or resale of the Notes.

          (d) Prior to the Closing Date, the Initial Purchasers will not issue
     any press release or other communication directly or indirectly or hold
     any press conference relating to the Notes without AMBEV's prior written
     consent (which shall not be unreasonably withheld), unless in the
     judgment of any of the Initial Purchasers and their counsel, and after
     notification to AMBEV, such press release or communication is required by
     law, or except as issued in accordance with the applicable regulations
     promulgated under the Securities Act or the Exchange Act.

          SECTION 5. Covenants. The Companies agree with each of the Initial
Purchasers that:

          (a) The Companies will furnish to the Representative and to counsel
     for the Initial Purchasers, without charge, during the period referred to
     in paragraph (c) below, as many copies of the Final Memorandum and any
     amendments and supplements thereto as they may reasonably request
     including the delivery of four copies of the Final Memorandum to the
     Representative, one of which shall be signed by duly authorized officers
     of the Companies.

          (b) The Companies will not amend or supplement the Final Memorandum
     without the prior written consent of the Representative.

          (c) If at any time prior to the completion of the sale of the Notes
     by the Initial Purchasers (as determined by the Representative), any
     event occurs as a result of which the Final Memorandum, as then amended
     or supplemented, would include any untrue statement of a material fact or
     omit to state any material fact necessary to make the



                                      14
<PAGE>



     statements therein, in the light of the circumstances under which they
     were made, not misleading, or if it should be necessary to amend or
     supplement the Final Memorandum to comply with applicable law, the
     Companies promptly (i) will notify the Representative of any such event,
     (ii) subject to the requirements of paragraph (b) of this Section 5, will
     prepare an amendment or supplement that will correct such statement or
     omission or effect such compliance and (iii) will supply any supplemented
     or amended Final Memorandum to the Representative and counsel for the
     Representative, without charge, in such quantities as the Representative
     may reasonably request.

          (d) AMBEV will arrange, if necessary, for the qualification of the
     Notes for sale by the Initial Purchasers under the laws of such
     jurisdictions as the Representative may designate and will maintain such
     qualifications in effect so long as required for the completion of the
     distribution of the Notes; provided, however, that in no event shall the
     Companies be obligated to qualify to do business in any jurisdiction
     where it is not now so qualified or to take any action that would subject
     it to service of process in suits, other than those arising out of the
     offering or sale of the Notes, in any jurisdiction where it is not now so
     subject. The Companies will promptly advise the Representative of the
     receipt by the either of the Companies of any notification with respect
     to the suspension of the qualification of the Notes for sale in any
     jurisdiction or the initiation or threatening of any proceeding for such
     purpose. The Companies will file such statements and reports as may be
     required by the laws of each jurisdiction in which the Notes have been
     qualified or registered as provided above.

          (e) Prior to the completion of the distribution of the Notes by the
     Initial Purchasers (as determined by the Representative), the Companies
     will not, and will not permit any of their Affiliates to, acquire any
     Notes.

          (f) Neither of the Companies, nor any of their Affiliates, nor any
     person acting on their behalf will, directly or indirectly, make offers
     or sales of any security, or solicit offers to buy any security, under
     circumstances that would require the registration of the Notes under the
     Securities Act.

          (g) Neither of the Companies, nor any of their Affiliates, nor any
     person acting on its or their behalf will engage in any form of general
     solicitation or general advertising (within the meaning of Regulation D)
     in connection with any offer or sale of the Notes in the United States.

          (h) So long as any of the Notes are "restricted securities" within
     the meaning of Rule 144(a)(3) under the Securities Act, AMBEV will, to
     the extent required by law, furnish CBB and the Trustee with the
     information necessary to permit the Trustee to provide to each holder of
     such restricted securities and to each prospective purchaser (as
     designated by such holder) of such restricted securities, upon the
     request of such holder or prospective purchaser, any information required
     to be provided by Rule 144A(d)(4) under the Securities Act during any
     period in which AMBEV is not subject to and in compliance with the
     reporting requirements of Sections 13 or 15(d) of the Exchange Act, nor
     exempt from such reporting requirements pursuant to Rule 12g3-2(b) under
     the Exchange Act. This covenant is intended to be for the benefit of the
     holders, and the



                                      15
<PAGE>



     prospective purchasers designated by such holders, from time to time of
     such restricted securities.

          (i) The Companies will cooperate with the Representative and will
     take all such action as is necessary to permit the Notes to be eligible
     for clearance and settlement through DTC.

          (j) Neither of the Companies will, for so long as the Notes are
     outstanding, be or become, or be or become owned by, an open-end
     investment company, unit investment trust or face-amount certificate
     company that is or is required to be registered under Section 8 of the
     Investment Company Act, and will not be or become, or be or become owned
     by a closed-end investment company required to be registered but no
     registered thereunder.

          (k) The Companies will not for a period of 90 days following the
     date hereof, without the prior written consent of the Representative,
     offer, sell or contract to sell, or otherwise dispose of or enter into
     any transaction which is designed to, or could reasonably be expected to,
     result in the disposition (whether by actual disposition or effective
     economic disposition due to cash settlement or otherwise) by the
     Companies or any of their Affiliates or any person in privity with the
     Companies or any of their Affiliates, directly or indirectly, or announce
     the offering of, or file a registration statement for, any debt
     securities substantially similar to the Notes issued or guaranteed by the
     Companies (other than the Notes, any export credit agency loans and
     trade-related facilities).

          (l) The Companies will not take, directly or indirectly, any action
     designed to or which has constituted or which could reasonably be
     expected to cause or result, under the Exchange Act or otherwise, in
     stabilization or manipulation of the price of any security of CBB or
     AMBEV to facilitate the sale or resale of the Notes.

          (m) The Companies will not and will request their Affiliates not to
     offer, sell or solicit offers to buy or otherwise negotiate in respect of
     any security (as defined in the Securities Act) the offering of which
     security could be integrated with the sale of the Notes in a manner that
     would require the registration of any of the Notes under the Securities
     Act.

          (n) Neither of the Companies nor any of their Affiliates, nor any
     person acting on their behalf, will engage in any directed selling
     efforts in the United States with respect to the Notes, and each of
     Companies will ensure that it and its Affiliates (and any other person
     acting on behalf thereof) will comply with any applicable offering
     restrictions of Regulation S.

          (o) CBB will use the net proceeds received by it from the sale of
     the Notes in the manner specified in the Final Memorandum under the
     caption "Use of Proceeds".

          (p) Prior to the Closing Date, neither of the Companies nor their
     Affiliates will issue any press release or other communications directly
     or indirectly or hold any press conference relating to the Notes, without
     the Representative's prior written consent



                                      16
<PAGE>



     (which shall not be unreasonably withheld), unless in the judgment of
     either of the Companies and its counsel, and after notification to the
     Representative, such press release or communication is required by law or
     except as issued in accordance with the applicable regulations
     promulgated under the Securities Act.

          (q) The Companies shall inform the Representative as promptly as is
     reasonably practicable, and shall confirm such information in writing,
     after they have been made aware of the suspension of qualifications of
     the Notes, for offering in any jurisdiction or the institution or threat
     of any proceeding for such purpose.

          (r) The Companies will pay any stamp, issue, registration,
     transaction or similar documentary taxes and duties, including interest
     and penalties, payable on or in connection with the creation, issue and
     offering of the Notes, or the execution or delivery of the Transaction
     Documents or the enforcement by the Initial Purchasers of this Purchase
     Agreement against the Companies or any transaction carried out pursuant
     to this Purchase Agreement; and, in addition to any amount payable by it
     under this Purchase Agreement, any value-added, turnover or similar tax
     payable in respect of that amount (and references in this Purchase
     Agreement to such amount shall be deemed to include any such taxes so
     payable in addition to it and express mention of such payment of any
     taxes (if applicable) in any provisions hereof shall not be construed as
     excluding such payment of any taxes in those provisions hereof where such
     express mention is not made). The Companies will indemnify the Initial
     Purchasers against any loss, liability, cost, claim, action, demand or
     expense (including, but not limited to, legal fees) which any of them may
     incur or which may be made against any of them arising out of or in
     relation to or in connection with any failure to pay or delay in paying
     any such taxes.

          (s) Neither the sale of the Notes nor the use of the proceeds
     thereof will violate any regulation of the United States Treasury
     Department contained in 31 C.F.R., Chapter V Subpart B or the
     International Money Laundering Statement and Financial Anti-Terrorism Act
     of 2001.

          (t) The Companies will furnish a copy of each amendment of the
     Transaction Documents to the Representative at its address set forth in
     Section 12 hereof.

          (u) The Companies agree to pay the costs and expenses relating to
     the following matters: (i) the preparation of each of the Transaction
     Documents, the issuance of the Notes and the fees of the Trustee, (ii)
     the preparation, printing or reproduction of the Preliminary Memorandum
     and Final Memorandum and all amendments or supplements to either of them,
     (iii) the costs of delivery (including postage, air freight charges and
     charges for counting and packaging) of such copies of the Preliminary
     Memorandum and Final Memorandum, and all amendments or supplements to
     either of them, as may, in each case, be reasonably requested for use in
     connection with the offering and sale of the Notes, (iv) the preparation,
     printing, authentication, issuance and delivery of certificates for the
     Notes, including any stamp, transfer or other similar taxes in connection
     with the original issuance and sale of the Notes, (v) the printing (or
     reproduction) and delivery of this Purchase Agreement, any blue sky
     memorandum and all other agreements or documents printed (or reproduced)
     and delivered in connection



                                      17
<PAGE>



     with the offering of the Notes, (vi) any registration or qualification of
     the Notes for offer and sale under the securities or blue sky laws of the
     several states (including filing fees and the reasonable fees and
     expenses of counsel for the Initial Purchasers relating to such
     registration and qualification), (vii) the transportation and other
     expenses incurred by or on behalf of Companies representatives in
     connection with presentations to prospective purchasers of the Notes,
     (viii) the fees and expenses of the Companies' accountants and the fees
     and expenses of counsel (including Brazilian and United States counsel)
     for the Companies, (ix) all fees, disbursements and expenses of the
     Initial Purchasers and counsel for the Initial Purchasers in accordance
     with the provisions set forth in the second paragraph under the caption
     "Expenses" of the letter dated August 4, 2003 from Citigroup Global
     Markets Inc. to CBB and AMBEV, (x) the fees and expenses of Moody's
     Investors Services ("Moody's"), Standard & Poor's ("S&P") and Fitch, Inc.
     ("Fitch") incurred in connection with the rating of the Notes and
     Exchange Notes, if any, (xi) the listing of the Notes and the Exchange
     Notes on the Luxembourg Stock Exchange and (xii) all other costs and
     expenses incident to the performance by CBB of its obligations hereunder.

          SECTION 6. Conditions to the Obligations of the Initial Purchasers.
The obligations of the Initial Purchasers to purchase the Notes shall be
subject to the following conditions:

          (a) On or prior to the Closing Date, the following shall have been
     executed and delivered to the Representative, each dated the Closing
     Date:

               (i) the Indenture duly executed and delivered by the Companies
          and the Trustee in form and substance acceptable to the
          Representative;

               (ii) a 144A Restricted Global Note and a Regulation S
          Unrestricted Global Note in the form attached to the Indenture, duly
          executed and delivered by CBB and duly authorized by the Trustee in
          accordance with the Indenture in such principal amount as the
          Representative shall direct (it being understood that the aggregate
          principal amount of such Notes shall equal $500,000,000), and
          otherwise in form and substance acceptable to the Representative;

               (iii) the Guaranty duly executed and delivered by AMBEV and the
          Trustee in form and substance acceptable to the Representative;

               (iv) the Registration Rights Agreement duly executed and
          delivered by the Companies in form and substance acceptable to the
          Representative;

               (v) the Insurance Policy duly executed and delivered by the
          Insurer in form and substance acceptable to the Representative; and

               (vi) the Insurance Side Agreement duly executed by the
          Companies, the Trustee and the Insurer in form and substance
          acceptable to the Representative.


                                      18
<PAGE>



          (b) The Reserve Account shall have been established as contemplated
     in the Indenture and the Initial Purchasers and the Trustee shall be
     satisfied that the Trustee has a first priority perfected security
     interest in the reserve account, all funds therein, all additions thereto
     and proceeds thereof under U.S. and Brazilian law; and all of the
     applicable taxes, fees and other charges due and owing in connection with
     the execution and delivery of the Transaction Documents shall have been
     paid.

          (c) On the Closing Date, each of CBB and AMBEV shall have furnished
     to the Representative a certificate concerning status under the
     Investment Company Act of 1940, in form satisfactory to the
     Representative.

          (d) On or prior to the Closing Date, the Insurer shall have
     furnished to the Representative a certificate of good standing certified
     by the Secretary of State of the State of Delaware and a copy of the
     license of the Insurer.

          (e) On the date hereof, the Representative shall have received from
     PricewaterhouseCoopers Auditores Independentes, independent public
     accountants for the Companies a comfort letter dated the date hereof
     addressed to the Initial Purchasers, in form and substance satisfactory
     to the Representative, concerning the financial statements and certain
     information with respect to the Companies set forth in the Final
     Memorandum.

          (f) On or prior to the Closing Date, the Representative shall have
     received from PricewaterhouseCoopers Auditores Independentes, independent
     public accountants for the Companies a "bring down" comfort letter, dated
     the Closing Date, in form and substance satisfactory to the
     Representative.

          (g) Moody's, S&P and Fitch shall each have delivered to CBB and the
     Initial Purchasers a final rating letter setting forth a rating with
     respect to the Notes of at least "Baa3", "BBB-" and "BBB-", respectively,
     and, subsequent to the date thereof, such rating agencies shall not have
     announced in writing that it has under surveillance or review, with
     possible negative implications, this rating of the Notes.

          (h) Application shall have been made to list the Notes on the
     Luxembourg Stock Exchange.

          (i) The Notes shall be eligible for clearance and settlement through
     DTC.

          (j) CBB shall have furnished to the Initial Purchasers a certificate
     of CBB, signed by an authorized officer of CBB acceptable to the
     Representative, dated the Closing Date and in form and substance
     satisfactory to the Representative, to the effect that:

               (i) the representations and warranties of CBB in this Purchase
          Agreement and any of the other Transaction Documents to which it is
          a party are true and correct in all material respects on and as of
          the Closing Date with the same effect as if made on the Closing
          Date, and CBB has complied with all the



                                      19
<PAGE>



          agreements and satisfied all the conditions on its part to be
          performed or satisfied hereunder at or prior to the Closing Date;

               (ii) since June 30, 2003, there has been no material adverse
          change in the condition (financial or otherwise), prospects,
          earnings, business or properties of CBB and its subsidiaries, taken
          as a whole, whether or not arising from transactions in the ordinary
          course of business, except as set forth in or contemplated by the
          Final Memorandum (exclusive of any amendment or supplement thereto);

               (iii) no Default or Event of Default (or other event that with
          the passage of time or notice, or both, will ripen into a Default or
          an Event of Default) under the Notes or the Indenture has occurred
          and is continuing as of the Closing Date;

               (iv) the incumbency of the officers or representatives of CBB
          signing the applicable Transaction Documents and the other documents
          delivered hereunder and thereunder on behalf of CBB and containing
          specimen signatures thereof; and

               (v) the Estatuto Social of CBB has not been amended and is in
          full force and effect, copies of which shall be attached to such
          certificate.

          (k) AMBEV shall have furnished to the Initial Purchasers a
     certificate, signed by an authorized officer of AMBEV acceptable to the
     Representative, dated the Closing Date and in form and substance
     satisfactory to the Representative, to the effect that:

               (i) the representations and warranties of AMBEV in this
          Purchase Agreement and any of the other Transaction Documents to
          which it is a party are true and correct in all material respects on
          and as of the Closing Date with the same effect as if made on the
          Closing Date, and AMBEV has complied with all the agreements and
          satisfied all the conditions on its part to be performed or
          satisfied hereunder at or prior to the Closing Date;

               (ii) since the date of the most recent financial statements
          included in the Final Memorandum (exclusive of any amendment or
          supplement thereto), there has been no material adverse change in
          the condition (financial or otherwise), prospects, earnings,
          business or properties of AMBEV and its subsidiaries, taken as a
          whole, whether or not arising from transactions in the ordinary
          course of business, except as set forth in or contemplated by the
          Final Memorandum (exclusive of any amendment or supplement thereto);

               (iii) no Default or Event of Default (or other event that with
          the passage of time or notice, or both, will ripen into a Default or
          an Event of Default) has occurred and is continuing as of the
          Closing Date;

               (iv) the incumbency of the officers or representatives of AMBEV
          signing the applicable Transaction Documents and the other documents
          delivered hereunder and thereunder on behalf of AMBEV and containing
          specimen signatures thereof; and



                                      20
<PAGE>



               (v) the Estatuto Social of AMBEV has not been amended and is in
          full force and effect, copies of which shall be attached to such
          certificate.

          (l) Subsequent to the date hereof and on or prior to the Closing
     Date hereunder, CBB shall have furnished to the Representative evidence
     satisfactory to the Representative that all approvals, authorizations or
     consents of or notices to, or registrations with, any governmental
     authority (including the Electronic Registration), required in connection
     with the execution and performance by CBB of its obligations under this
     Purchase Agreement and by CBB and AMBEV of their obligations under the
     other Transaction Documents have been obtained and are in full force and
     effect.

          (m) The Trustee shall have furnished to the Representative a
     certificate of the Trustee, signed by an authorized officer of the
     Trustee acceptable to the Representative, dated the Closing Date, (i)
     stating that the Trustee is a banking corporation organized and validly
     existing under the laws of the State of New York and that its principal
     office and place of business is not located in Brazil, (ii) regarding the
     authority of the Trustee to enter into the Transaction Documents to which
     it is a party and to execute all documents related thereto and (iii)
     regarding the incumbency of its officers executing such documents.

          (n) Subsequent to the date hereof and on or prior to the Closing
     Date hereunder, there shall not have been any decrease in the rating of
     any of the Companies' debt securities by any "nationally recognized
     statistical rating organization" (as defined for the purposes of Rule
     436(g) under the Securities Act) or any notice given of any intended or
     potential decrease in any such rating or of a possible change in any such
     rating that does not indicate the direction of such possible change, or
     any withdrawal of any such rating.

          (o) Subsequent to the date hereof and on or prior to the Closing
     Date hereunder, no legislation shall have been enacted by either house of
     the United States or Brazilian congress or by any state legislature or
     any political subdivision of the United States or Brazil, no other action
     shall have been taken by any Governmental Authority, whether by order,
     regulation, rule, ruling or otherwise, and no decision shall have been
     rendered by any court of competent jurisdiction in the United States,
     Brazil or any other country, which would have a Material Adverse Effect.

          (p) On the Closing Date, none of the events listed below shall have
     occurred and be continuing:

               (i) a default in the performance or observance by the Companies
          of any covenant or agreement made by it under this Purchase
          Agreement or any other Transaction Document to which they are a
          party; or

               (ii) proceedings shall have been commenced against either of
          the Companies, the Insurer or the Trustee under any Brazilian, U.S.
          or other



                                      21
<PAGE>



          bankruptcy act or other foreign, federal or state law relating to
          bankruptcy or insolvency or laws relating to the relief of debtors,
          readjustments of indebtedness, reorganizations, arrangements,
          compositions or extensions, or appointing a receiver or decreeing or
          ordering the winding up or liquidation of the affairs of either
          Company, the Insurer or the Trustee or similar proceedings for any
          relief which includes or might result in, any material modification
          of the obligations of either Company, the Insurer or the Trustee
          hereunder or under the applicable Transaction Documents; or

               (iii) either Company, the Insurer or the Trustee shall have
          instituted proceedings to be adjudicated insolvent or a bankrupt or
          shall have consented to the institution of bankruptcy or insolvency
          proceedings against it or shall have filed a petition or answer or
          consent seeking reorganization or relief under any Brazilian, U.S.
          or other bankruptcy act or any other federal or state law relating
          to bankruptcy or insolvency or shall have consented to the
          appointment of a receiver or shall have made an assignment for the
          benefit of creditors or shall have admitted in writing its inability
          to pay its debts by either Company, the Insurer or the Trustee in
          furtherance of any of the aforesaid purposes.

          (q) Subsequent to the date hereof or, if earlier, the dates as of
     which information is given in the Final Memorandum (exclusive of any
     amendment or supplement thereto) and on or prior to the closing of the
     issuance of the Notes, there shall not have been (i) any material change
     or decrease in any of the financial line items specified in the letter or
     letters referred to in paragraphs (e) and (f) of this Section 6 or (ii)
     any change, or any development involving a prospective change, in or
     affecting the condition (financial or otherwise), prospects, earnings,
     business or properties of the Companies and their subsidiaries, taken as
     a whole, whether or not arising from transactions in the ordinary course
     of business, except as set forth or contemplated in the Final Memorandum
     (exclusive of any amendment or supplement thereto) the effect of which,
     in any case referred to in clause (i) or (ii) above, is, in the judgment
     of the Representative, so material and adverse as to make it impractical
     or inadvisable to market the Notes as contemplated by the Final
     Memorandum (exclusive of any amendment or supplement thereto).

          (r) The Representative shall have received from Cravath, Swaine &
     Moore LLP, special New York counsel to the Companies, an opinion, dated
     the Closing Date and addressed to the Initial Purchasers, in form and
     substance acceptable to the Representative.

          (s) The Representative shall have received from Barbosa, Mussnich &
     Aragao Advogados, Brazilian counsel to the Companies, an opinion, dated
     the Closing Date and addressed to the Initial Purchasers, in form and
     substance acceptable to the Representative.

          (t) The Representative shall have received an opinion of internal
     counsel to the Insurer, dated the Closing Date and addressed to the
     Initial Purchasers, in form and substance acceptable to the
     Representative.



                                      22
<PAGE>



          (u) The Representative shall have received an opinion of Emmet,
     Marvin & Martin, LLP, external New York counsel to the Trustee, dated the
     Closing Date and addressed to the Initial Purchasers, in form and
     substance acceptable to the Representative.

          (v) The Representative shall have received an opinion of Pinheiro
     Neto - Advogados, special Brazilian counsel for the Initial Purchasers,
     in form and substance acceptable to the Representative (it being
     understood that the Companies shall have furnished to such counsel such
     documents as they request for the purposes of enabling them to pass on
     such matters).

          (w) The Representative shall have received an opinion from Shearman
     & Sterling LLP, special New York counsel to the Initial Purchasers, dated
     the Closing Date and addressed to the Initial Purchasers, and the
     Companies shall have furnished to such counsel such documents as they
     request for the purpose of enabling them to pass upon such matters.

          (x) The Companies shall have furnished to the Representative such
     further information, certificates and documents as the Representative may
     reasonably request.

          (y) The Representative shall be satisfied that payments to be made
     to it pursuant to Section 2 hereof will be made on the Closing Date.

          (z) On the Closing Date, the Trustee shall have received the Letter
     of Credit in form and substance acceptable to the Representative.

          If any of the conditions specified in this Section 6 shall not have
been fulfilled in all material respects when and as provided in this Purchase
Agreement, or if any of the opinions and certificates mentioned above or
elsewhere in this Purchase Agreement shall not be in all material respects
reasonably satisfactory in form and substance to the Representative and
counsel for the Representative, this Purchase Agreement and all obligations of
the Initial Purchasers hereunder may be canceled at, or at any time prior to,
the Closing Date by the Representative. Notice of such cancellation shall be
given to CBB in writing or by telephone or facsimile confirmed in writing.

          The documents required to be delivered by this Section 6 will be
delivered at the office of counsel for the Initial Purchasers, at 599
Lexington Avenue, New York, N.Y. 10022, on the Closing Date.

          SECTION 7. Reimbursement of Expenses. If the sale of the Notes
provided for herein is not consummated because any condition to the
obligations of the Initial Purchasers set forth in Section 6 hereof is not
satisfied, because of any termination pursuant to Section 9 hereof or because
of any refusal, inability or failure on the part of either of the Companies to
perform any agreement herein or comply with any provision hereof other than by
reason of a default by the Initial Purchasers, the Companies will reimburse
the Initial Purchasers on demand for all reasonable and properly documented
fees, disbursements and expenses of the Initial Purchasers and counsel for the
Initial Purchasers (as such fees, disbursement and expenses are limited in
accordance with the provisions set forth in the second paragraph under the
caption "Expenses" of



                                      23
<PAGE>



the letter dated August 4, 2003 from Citigroup Global Markets Inc. to CBB and
AMBEV) that shall have been incurred by them in connection with the proposed
purchase and sale of the Notes; provided that if the Representative, on behalf
of the Initial Purchasers resigns without having good commercial reasons for
resigning (having regard to good international capital markets practice), then
the Companies shall be under no obligation to reimburse such expenses. The
Companies' liability to the Initial Purchasers under this Section 7 is joint
and several.

          SECTION 8. Indemnification and Contribution. (a) The Companies agree
to indemnify and hold harmless the Initial Purchasers, the directors,
officers, employees and agents of the Initial Purchasers and each person who
controls any of the Initial Purchasers within the meaning of either the
Securities Act or the Exchange Act against any and all losses, claims, damages
or liabilities, joint or several, to which they or any of them may become
subject under the Securities Act, the Exchange Act or other Federal or state
statutory law or regulation, at common law or otherwise, insofar as such
losses, claims, damages or liabilities (or actions in respect thereof) arise
out of or are based upon any untrue statement or alleged untrue statement of a
material fact contained in the Preliminary Memorandum, the Final Memorandum or
any information provided by the Companies to any holder or prospective
purchaser of the Notes pursuant to Section 5(h), or in any amendment thereof
or supplement thereto, or arise out of or are based upon the omission or
alleged omission to state therein a material fact required to be stated
therein or necessary to make the statements therein, in the light of the
circumstances under which they were made, not misleading, and agrees to
reimburse each such indemnified party, as incurred, for any properly
documented legal or other expenses reasonably incurred by them in connection
with investigating or defending any such loss, claim, damage, liability or
action; provided, however, that the Companies will not be liable in any such
case to the extent that any such loss, claim, damage or liability arises out
of or is based upon any such untrue statement or alleged untrue statement or
omission or alleged omission made in the Preliminary Memorandum or the Final
Memorandum, or in any amendment thereof or supplement thereto, in reliance
upon and in conformity with written information relating to the Initial
Purchasers furnished to the Companies by or on behalf of the Initial
Purchasers or by or on behalf of the Insurer specifically for inclusion
therein and provided further, that the foregoing indemnity agreement with
respect to any Preliminary Memorandum shall not inure to the benefit of any
Initial Purchaser from whom the person asserting any such losses, claims,
damages or liabilities purchased Notes if a copy of the Final Memorandum (as
then amended or supplemented if CBB or AMBEV shall have furnished any
amendments or supplements thereto) was not sent or given by or on behalf of
such Initial Purchasers to such person, if required by law so to have
delivered, at or prior to the written confirmation of the sale of the Notes to
such person, and if the Final Memorandum (as so amended or supplemented) would
have cured the defect giving rise to such losses, claims, damages or
liabilities, unless such failure is the result of noncompliance by CBB or
AMBEV of Section 5(a) hereof.. This indemnity agreement will be in addition to
any liability which the Companies may otherwise have.

          (b) The Initial Purchasers agree to indemnify and hold harmless the
Companies, each of their directors, each of its officers, each of its
employees and agents, and each person who controls the Companies within the
meaning of either the Securities Act or the Exchange Act, to the same extent
(subject to the proviso set forth below) as the foregoing indemnity from the
Companies to the Initial Purchasers, but only with reference to written
information (contained in the chart and the seventh paragraph (regarding
stabilization and over-



                                      24
<PAGE>



allotment transaction) following the chart under the caption "Plan of
Distribution" in the Final Memorandum) relating to the Initial Purchasers
furnished to the Companies by or on behalf of the Initial Purchasers
specifically for inclusion in the Preliminary Memorandum or the Final
Memorandum (or in any amendment or supplement thereto) provided that the
Initial Purchasers' aggregate liability to the parties set forth above shall
in no event exceed the amount of the Selling Commission. This indemnity
agreement will be in addition to any liability which the Initial Purchasers
may otherwise have.

          (c) Promptly after receipt by an indemnified party under this
Section 8 of notice of the commencement of any action, such indemnified party
will, if a claim in respect thereof is to be made against the indemnifying
party under this Section 8, notify the indemnifying party in writing of the
commencement thereof; but the failure so to notify the indemnifying party (i)
will not relieve it from liability under paragraph (a) or (b) above unless and
to the extent it did not otherwise learn of such action and such failure
results in the forfeiture by the indemnifying party of substantial rights and
defenses and (ii) will not, in any event, relieve the indemnifying party from
any obligations to any indemnified party other than the indemnification
obligation provided in paragraph (a) or (b) above. The indemnifying party
shall be entitled to appoint counsel of the indemnifying party's choice at the
indemnifying party's expense to represent the indemnified party in any action
for which indemnification is sought (in which case the indemnifying party
shall not thereafter be responsible for the fees and expenses of any separate
counsel retained by the indemnified party or parties except as set forth
below); provided, however, that such counsel shall be reasonably satisfactory
to the indemnified party. Notwithstanding the indemnifying party's election to
appoint counsel to represent the indemnified party in an action, the
indemnified party shall have the right to employ separate counsel (including
local counsel), and the indemnifying party shall bear the reasonable fees,
costs and expenses of such separate counsel if (i) the use of counsel chosen
by the indemnifying party to represent the indemnified party would present
such counsel with a conflict of interest, (ii) the actual or potential
defendants in, or targets of, any such action include both the indemnified
party and the indemnifying party and the indemnified party shall have
reasonably concluded that there may be legal defenses available to it and/or
other indemnified parties which are different from or additional to those
available to the indemnifying party, (iii) the indemnifying party shall not
have employed counsel satisfactory to the indemnified party to represent the
indemnified party within a reasonable time after notice of the institution of
such action or (iv) the indemnifying party shall authorize the indemnified
party to employ separate counsel at the expense of the indemnifying party. An
indemnifying party will not, without the prior written consent of the
indemnified parties, settle or compromise or consent to the entry of any
judgment with respect to any pending or threatened claim, action, suit or
proceeding in respect of which indemnification or contribution may be sought
hereunder (whether or not the indemnified parties are actual or potential
parties to such claim or action) unless such settlement, compromise or consent
includes an unconditional release of each indemnified party from all liability
arising out of such claim, action, suit or proceeding.

          (d) In the event that the indemnity provided in paragraph (a) or (b)
of this Section 8 is unavailable to or insufficient to hold harmless an
indemnified party for any reason, the Companies and the Initial Purchasers
agree to contribute to the aggregate losses, claims, damages and liabilities
(including legal or other expenses reasonably incurred in connection with
investigating or defending same) (collectively "Losses") to which the
Companies and the Initial



                                      25
<PAGE>



Purchasers may be subject in such proportion as is appropriate to reflect the
relative benefits received by the Companies (on the one hand) and by the
Initial Purchasers (on the other) from the offering of the Notes. If the
allocation provided by the immediately preceding sentence is unavailable for
any reason, the Companies and the Initial Purchasers shall contribute in such
proportion as is appropriate to reflect not only such relative benefits but
also the relative fault of the Companies (on the one hand) and of the Initial
Purchasers (on the other) in connection with the statements or omissions which
resulted in such Losses, as well as any other relevant equitable
considerations. Benefits received by the Companies shall be deemed to be equal
to the total net proceeds from the offering (before deducting expenses)
received by CBB, and benefits received by the Initial Purchasers shall be
deemed to be equal to the total amount of the Selling Commission. Relative
fault shall be determined by reference to, among other things, whether any
untrue or any alleged untrue statement of a material fact or the omission or
alleged omission to state a material fact relates to information provided by
the Companies (on the one hand) or the Initial Purchasers (on the other), the
intent of the parties and their relative knowledge, access to information and
opportunity to correct or prevent such untrue statement or omission. Each of
the Companies and the Initial Purchasers agree that it would not be just and
equitable if contribution were determined by pro rata allocation or any other
method of allocation which does not take account of the equitable
considerations referred to above. Notwithstanding the provisions of this
paragraph (d), no person guilty of fraudulent misrepresentation (within the
meaning of Section 11(f) of the Securities Act) shall be entitled to
contribution from any person who was not guilty of such fraudulent
misrepresentation. For purposes of this Section 8, each person who controls
any of the Initial Purchasers within the meaning of either the Securities Act
or the Exchange Act and each director, officer, employee and agent of any of
the Initial Purchasers shall have the same rights to contribution as the
Initial Purchasers, and each person who controls either of the Companies
within the meaning of either the Securities Act or the Exchange Act and each
officer and director of either of the Companies shall have the same rights to
contribution as the Companies, subject in each case to the applicable terms
and conditions of this paragraph (d). The Companies and the Initial Purchasers
agree that it would not be just and equitable if contribution pursuant to this
Section 8 were determined by pro rata allocation (even if the Initial
Purchasers were treated as one entity for such purpose) or by any other method
of allocation that does not take account of the equitable considerations
referred to in subsection (c) above. Notwithstanding the provisions of this
Section 8, no Initial Purchaser shall be required to contribute any amount in
excess of the amount by which its percentage of the total Selling Commission
exceeds the amount of any damage which such Initial Purchaser has otherwise
been required to pay by reason of such untrue statement or alleged untrue
statement or omission or alleged omission.

          (e) The liability of each of the Companies under this Section 8 is
joint and several.

          SECTION 9. Termination. This Purchase Agreement shall be subject to
termination in the absolute discretion of the Representative, by notice given
to the Companies prior to delivery of and payment for the Notes, if at any
time prior to such time (i) trading in any of AMBEV's securities shall have
been suspended by the Sao Paulo Stock Exchange (BOVESPA) or trading in
securities generally on the New York Stock Exchange or the Sao Paulo Stock
Exchange (BOVESPA) shall have been suspended or limited or minimum prices
shall have been established on either such exchanges, (ii) a banking
moratorium shall have been declared either by Federal or New York State
authorities or by the relevant banking authorities in



                                      26
<PAGE>



Brazil or (iii) there shall have occurred any outbreak or escalation of
hostilities, declaration by the United States of a national emergency or war
or other calamity (including any major terrorist act) or crisis the effect of
which on financial markets is such as to make it, in the sole judgment of the
Representative, impracticable or inadvisable to proceed with the offering or
delivery of the Notes as contemplated by the Final Memorandum (exclusive of
any amendment or supplement thereto).

          SECTION 10. Representations and Indemnities to Survive. The
respective agreements, representations, warranties, indemnities and other
statements of each of the Companies or their officers and of the Initial
Purchasers set forth in or made pursuant to this Purchase Agreement will
remain in full force and effect, regardless of any investigation made by or on
behalf of the Initial Purchasers or the Companies or any of the officers,
directors or controlling persons referred to in Section 8 hereof, and will
survive delivery of and payment for the Notes. The provisions of Sections 7
and 8 hereof shall survive the termination or cancellation of this Purchase
Agreement.

          SECTION 11. Notices. All communications hereunder will be in writing
and effective only on receipt, and, if sent to the Initial Purchasers, will be
mailed, delivered or telefaxed to General Counsel, Citigroup Global Markets
Inc., at 388 Greenwich Street, New York, New York 10013, Attention: General
Counsel, telefax: (1-212) 816-7912 (with a courtesy copy to Alexander
Severino, telefax: (1-212) 723-8658) or if sent to CBB and/or AMBEV, will be
mailed, delivered or telefaxed to AMBEV, Edificio Corporate Park, Rua Dr.
Renato Paes de Barros 1017, 4(degree) andar, 04530-001, Sao Paulo, SP, Brasil,
Attention: Tobias Stingelin and Andrea Vianna Jorge Ruiz (telefax: (55-11)
2122-1454 and (55-11) 2122-1540).

          SECTION 12. Successors. This Purchase Agreement will inure to the
benefit of and be binding upon the parties hereto and their respective
successors and the officers and directors and controlling persons referred to
in Section 8 hereof, and, except as expressly set forth in Section 5(h)
hereof, no other person will have any right or obligation hereunder.

          SECTION 13. Jurisdiction. Each of CBB, AMBEV and the Initial
Purchasers agree that any suit, action or proceeding against them, arising out
of or based upon this Purchase Agreement or the transactions contemplated
hereby, may be instituted in any State or Federal court in The City of New
York, New York, or in the competent courts of their own corporate domiciles
with respect to actions brought against any of them as a defendant, and waive
any objection which they may now or hereafter have to the laying of venue of
any such proceeding and any right to which any of them may be entitled on
account of places of residence or domicile, and irrevocably submit to the
jurisdiction of such courts in any suit, action or proceeding. The Companies
have appointed CT Corporation System, at its offices located at 111 Eighth
Avenue, New York, New York 10011 as its authorized agent (the "Authorized
Agent") upon whom process may be served in any suit, action or proceeding
arising out of or based upon this Purchase Agreement or the transactions
contemplated herein which may be instituted in any State or Federal court in
The City of New York, New York, by the Initial Purchasers, the directors,
officers, employees and agents of the Initial Purchasers, or by any person who
controls any of the Initial Purchasers, and expressly accepts the jurisdiction
of any such court in respect of any such suit, action or proceeding. The
Companies hereby represent and warrant that the Authorized Agent has accepted
such appointments and has agreed to act as said agent for service



                                      27
<PAGE>



of process, and the Companies agree to take any and all action, including the
filing of any and all documents that may be necessary to continue such
appointment in full force and effect as aforesaid. Subject to applicable law,
service of process upon the Authorized Agent shall be deemed, in every
respect, effective service of process upon each of the Companies.

          SECTION 14. Governing Law. This Purchase Agreement will be governed
by and construed in accordance with the laws of the State of New York.

          SECTION 15. Currency. Each reference in this Purchase Agreement to
U.S. dollars is of the essence. To the fullest extent permitted by law, the
obligation of CBB in respect of any amount due under this Purchase Agreement
will, notwithstanding any payment in any other currency (whether pursuant to a
judgment or otherwise), be discharged only to the extent of the amount in U.S.
dollars that the party entitled to receive such payment may, in accordance
with its normal procedures, purchase with the sum paid in such other currency
(after any premium and costs of exchange) on the Business Day immediately
following the day on which such party receives such payment. If the amount in
U.S. dollars that may be so purchased for any reason falls short of the amount
originally due, the applicable Company will pay such additional amounts, in
U.S. dollars, as may be necessary to compensate for the shortfall. Any
obligation of the Companies not discharged by such payment will, to the
fullest extent permitted by applicable law, be due as a separate and
independent obligation and, until discharged as provided herein, will continue
in full force and effect.

          SECTION 16. Waiver of Immunity. This Purchase Agreement, the other
Transaction Documents and any other documents delivered pursuant hereto or
thereto, and any actions taken hereunder or thereunder, constitute commercial
acts by each of the Companies. Each of the Companies irrevocably and
unconditionally and to the fullest extent permitted by law, waives, and agrees
not to plead or claim, any immunity from jurisdiction of any court or from any
legal process (whether through service or notice, attachment prior to
judgment, attachment in aid of execution, execution or otherwise) for itself
of any of its property, assets or revenues wherever located with respect to
its obligations, liabilities or any other matter under or arising out of or in
connection with this Purchase Agreement, the other Transaction Documents, or
any document delivered pursuant hereto or thereunder, in each case for the
benefit of each assigns, it being intended that the foregoing waiver and
agreement will be effective, irrevocable and not subject to withdrawal in any
and all jurisdiction, and, without limiting the generality of the foregoing,
agrees that the waivers set forth in this Section 16 shall have the fullest
scope permitted under the United States Foreign Sovereign Immunities Act of
1976 and are intended to be irrevocable for the purposes of such act.

          SECTION 17. Counterparts. This Purchase Agreement may be executed in
one or more counterparts (including via telecopier), each of which shall
constitute an original and all of which together shall constitute one and the
same instrument.

          SECTION 18. Entire Agreement. This Purchase Agreement sets forth the
entire agreement of the parties hereto with respect to the subject matter
hereof.

          SECTION 19. Headings. The section headings used herein are for
convenience only and shall not affect the construction hereof.



                                      28
<PAGE>



          If the foregoing is in accordance with your understanding of our
agreement, please sign and return to us the enclosed duplicate hereof,
whereupon this Purchase Agreement and your acceptance shall represent a
binding agreement among CBB, AMBEV and the Initial Purchasers.

                                       Very truly yours,


                                       COMPANHIA BRASILEIRA DE BEBIDAS


                                       By:
                                           ------------------------
                                           Name:
                                           Title:

                                       By:
                                           ------------------------
                                           Name:
                                           Title:

                                       COMPANHIA DE BEBIDAS DAS AMERICAS -
                                       AMBEV


                                       By:
                                           ------------------------
                                           Name:
                                           Title:

                                       By:
                                           ------------------------
                                           Name:
                                           Title:

WITNESSES:

     ----------------------------
     Name:


     ----------------------------
     Name:




                                      29
<PAGE>



The foregoing Agreement is hereby
confirmed and accepted as of the
date first above written.

CITIGROUP GLOBAL MARKETS INC.,
as Representative on behalf of the Initial Purchasers
set forth on Schedule I hereto

By:  ----------------------------
     Name:
     Title:

WITNESSES:

     ----------------------------
     Name:


     ----------------------------
     Name:



                                      30
<PAGE>



STATE OF NEW YORK          )
                           ) ss:
COUNTY OF NEW YORK         )


     On this 11th day of September, 2003 before me, a notary public within and
for said county, personally appeared ____________________ to me personally
known who being duly sworn, did say that he is a __________________ of
Citigroup Global Markets Inc., one of the persons described in and which
executed the foregoing instrument, and acknowledge said instrument to be the
free act and deed of said corporation.



     On this 11th day of September, 2003, before me personally came
______________________ and ______________________ to me personally known, who
being by me sworn, did depose and say that they signed their names to the
foregoing instrument as witnesses.





                                       -------------------------------
                                       Notary Public
                                       COMMISSION EXPIRES


[Notarial Seal]




                                      31
<PAGE>



STATE OF NEW YORK          )
                           ) ss:
COUNTY OF NEW YORK         )


     On this 11th day of September, 2003 before me, a notary public within and
for said county, personally appeared ______________________ and
______________________, to me personally known who being duly sworn, did say
that they are each a ____________________ and a _________________,
respectively of Companhia Brasileira de Bebidas and Companhia de Bebidas das
Americas - AMBEV, each a person described in and which executed the foregoing
instrument, and acknowledge said instrument to be the free act and deed of
said corporation.



     On this 11th day of September, 2003, before me personally came
______________________ and ____________________ to me personally known, who
being by me sworn, did depose and say that they signed their names to the
foregoing instrument as witnesses.






                                       -------------------------------
                                       Notary Public
                                       COMMISSION EXPIRES
[Notarial Seal]





                                      32
<PAGE>

                                                                    SCHEDULE I


                              Initial Purchasers


                                                          Principal Amount of
     Name                                                  Notes Commitment
     ----                                                  ----------------

Citigroup Global Markets Inc. ............................ U.S.$475,000,000
J.P. Morgan Securities Inc. .............................. U.S.$25,000,000

                                                           ----------------
                                                           U.S.$500,000,000






<PAGE>



                                                                     EXHIBIT A

      Selling Restrictions for Offers and Sales outside the United States
      -------------------------------------------------------------------

     1. (a) The Notes have not been and will not be registered under the Act
and may not be offered or sold within the United States or to, or for the
account or benefit of, U.S. persons except in accordance with Regulation S
under the Act or pursuant to an exemption from the registration requirements
of the Act. The Initial Purchasers represent and agree that, except as
otherwise permitted by Section 6(a)(i) or (ii) of the Purchase Agreement to
which this is an exhibit, it has offered and sold the Notes, and will offer
and sell the Notes, (i) as part of their distribution at any time; and (ii)
otherwise until 40 days after the later of the commencement of the offering
and the Closing Date, only in accordance with Rule 903 of Regulation S under
the Act. Accordingly, the Initial Purchasers represent and agree that neither
it, nor any of its Affiliates nor any person acting on its or their behalf has
engaged or will engage in any directed selling efforts with respect to the
Notes, and that it and they have complied and will comply with the offering
restrictions requirement of Regulation S. The Initial Purchasers agree that,
at or prior to the confirmation of sale of Notes (other than a sale of Notes
pursuant to Section 6(a)(i) or (ii) of the Purchase Agreement to which this is
an exhibit), it shall have sent to each distributor, dealer or person
receiving a selling concession, fee or other remuneration that purchases Notes
from it during the distribution compliance period a confirmation or notice to
substantially the following effect:

     "The Notes covered hereby have not been registered under the U.S.
     Securities Act of 1933 (the "Securities Act") and may not be offered
     or sold within the United States or to, or for the account or
     benefit of, U.S. persons (i) as part of their distribution at any
     time or (ii) otherwise until 40 days after the later of the
     commencement of the offering and December 19, 2001, except in either
     case in accordance with Regulation S or Rule 144A under the Act.
     Terms used above have the meanings given to them by Regulation S."

     (b) Each Initial Purchaser also represents and agrees that it has not
entered and will not enter into any contractual arrangement with any
distributor with respect to the distribution of the Notes, except with its
Affiliates or with the prior written consent of the Company.

     (c) Terms used in this section have the meanings given to them by
Regulation S.

     2. Each of the Initial Purchasers represents and agrees that (a) it (or
any of its affiliates) has not offered or sold and, prior to the expiry of the
period of six months from the issue date of the Notes, will not offer or sell
any Notes to persons in the United Kingdom, except to persons whose ordinary
activities involve the acquiring, holding, managing or disposing of
investments (as principal or agent) for the purposes of its businesses or
otherwise in circumstances which have not resulted and will not result in an
offer to the public in the United Kingdom within the meaning of the Public
Offers of Securities Regulations 1995 or the Financial


<PAGE>



Services and Markets Act 2000 (the "FSMA") (as amended); (b) it is a person
whose ordinary activities involve the acquiring, holding, managing or
disposing of investments (as principal or agent) for the purposes of its
business and they have not offered or sold and will not offer or sell any
Notes other than to persons whose ordinary activities involve the acquiring,
holding, managing or disposing of investments (as principal or agent) for the
purposes of its businesses or who it is reasonable to expect will acquire,
hold, manage or dispose of investments (as principal or agent) for the
purposes of their businesses where the issue of the Notes would otherwise
constitute a contravention of section 19 of the FSMA by CBB; (c) it has only
issued or passed on and will only issue or pass on in the United Kingdom,
before the repeal of Section 57 of the FSA any document received by it in
connection with the issue of the Notes to a person who is of a kind described
in Article 11(3) of the Financial Services Act of 1986 (Investment
Advertisements) (Exemptions) Order 1996 (as amended) or is a person to whom
such document may otherwise lawfully be issued or passed on and, after the
repeal of Section 57 of the FSA, it will only communicate or cause to be
communicated any invitation or inducement to engage in investment activity
(within the meaning of section 21 of the FSMA) received by it in connection
with the issue or sale of any Notes in circumstances in which section 21(1) of
the FSMA does not apply to the CBB or AMBEV; (d) it has complied and will
comply with all applicable provisions of the Financial Services Act 1986
("FSA") and, after they come into force, all applicable provisions of the FSMA
with respect to anything done by it in relation to the Notes in, from or
otherwise involving the United Kingdom.

     3. No sales of the Notes will be made in Brazil except in compliance with
the laws of Brazil. 5




                                     A-2